Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
American Renal Associates Holdings, Inc. (ARA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/05/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/27/2021 |
SC 13G/A
| Centerbridge Credit Partners, L.P. reports a 0% stake in American Renal Associates Holdings, Inc. |
| 01/26/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/26/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/26/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/26/2021 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...|
Docs:
|
"Fourth Amended and Restated Certificate of Incorporation of American Renal Associates Holdings, Inc",
"Second Amended and Restated Bylaws of American Renal Associates Holdings, Inc",
"BEVERLY, Mass. — Nautic Partners and its portfolio company, Innovative Renal Care , have completed the previously announced transaction to acquire American Renal Associates Holdings, Inc. , effective January 25, 2021. The transaction creates a unique opportunity to shape the future of kidney care during a dynamic time of change, innovation and transformation in the industry. “As the healthcare industry continues to evolve, recent innovation throughout kidney and renal care has allowed for dramatic and exciting improvements in care delivery and patient experience,” said Nick Mendez, president and CEO of IRC. “ARA’s significant infrastructure and geographic footprint provides a unique opportunity to advance the development of a comprehensive renal care model for the patients and communities ..." |
|
| 01/14/2021 |
8-K
| Quarterly results |
| 01/06/2021 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/30/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – WTRE, ARA, RESI, NK |
| 12/24/2020 |
GN
| ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers – STND, EIDX, ARA, RESI |
| 12/15/2020 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 12/01/2020 |
GN
| Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – ARA, PNM, IPHI, EIGI |
| 12/01/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, ARA, PNM, and EIGI Buyouts |
| 11/25/2020 |
GN
| Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm ?? ARA, CIT, CXO, RESI |
| 11/25/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ARA, CEIX, MVC, and MCEP Mergers |
| 11/24/2020 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 11/07/2020 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – EIDX, WTRE, ARA, CIT |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 10/30/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and CIT Group Inc. (NYSE:CIT) and Mid-Con Energy Partners, LP (NASDAQ: MCEP) |
| 10/19/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Cellular Biomedicine Group, Inc., and Eidos Therapeutics, Inc. |
| 10/09/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/05/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of American Renal Associates Holdings, Inc. Buyout |
| 10/02/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/02/2020 |
8-K/A
| Quarterly results |
| 10/02/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/02/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/02/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/02/2020 |
8-K
| Quarterly results |
| 09/18/2020 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/10/2020 |
8-K
| Quarterly results |
| 08/10/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 07/09/2020 |
8-K
| Quarterly results |
| 05/15/2020 |
8-K/A
| Quarterly results |
|
|
|